Saturday 17 October 2026
Export BWAY’s income statement to Excel — free account
Brainsway Ltd. Sponsored ADR
BWAY Healthcare Medical Devices
Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.4%, EPS grew 40.0% and free cash flow fell 51.7%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
11.41
0.41
−3.47%
Follow BWAY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 6 | 7 | 6 |
| 10.95% | 11.18% | 12.55% | 12.82% | ||
| 6.75% | 7.30% | 8.06% | 8.09% | ||
ROIC |
0.00% | 71.48% | 22.79% | 29.98% | |
Return on Tangible Assets |
10.82% | 12.19% | 15.65% | 15.84% | |
Average Days of Receivables |
38.13 | 28.73 | 48.89 | 42.29 | |
Free Cash Flow per Share |
0.47 | 0.80 | 0.61 | 0.30 | |
Free Cash Flow |
18.34 | 15.15 | 11.58 | 5.79 | |
Capital Expenditures |
(3.93) | (2.34) | (2.07) | (1.78) | |
| Other line items | |||||
Cash ROIC |
12.93% | 10.63% | 8.53% | 4.06% | |
Accounts Receivable Turnover |
11.35 | 12.00 | 7.76 | 11.13 | |
Accounts Payable Turnover |
6.07 | 4.85 | 5.47 | 8.07 | |
Inventory Turnover |
3.04 | 2.35 | 2.34 | 2.60 | |
Average Days of Payables |
82.72 | 69.03 | 77.62 | 61.00 | |
Days of Inventory on Hand |
130.94 | 185.44 | 187.63 | 178.15 | |
Tax Rate |
(0.10) | (0.02) | (0.01) | (0.02) | |
Research and Development Expense of Revenue |
18.57% | 18.39% | 18.06% | 18.17% | |
Selling, General and Administrative Expense of Revenue |
50.57% | 48.75% | 47.22% | 44.69% | |
Share Based Compensation of Revenue |
2.65% | 2.29% | 2.16% | 2.72% | |
Interest Coverage |
1.26 | 1.96 | 2.96 | 3.71 | |
Operating CF/Net income |
3.56 | 2.31 | 1.56 | 0.80 | |
Depreciation/Fixed assets |
2.41 | 1.95 | 1.83 | 1.92 | |
Capex/Depreciation |
(2.08) | (1.52) | (1.28) | (1.07) | |
Revenue per Share |
1.25 | 2.75 | 2.95 | 3.14 | |
Operating CF per Share |
0.57 | 0.92 | 0.72 | 0.39 | |
Capex per Share |
(0.10) | (0.12) | (0.11) | (0.09) | |
Capex to Sales |
0.08 | 0.04 | 0.04 | 0.03 |
Columns are period end dates